Xi'an Jiefang Trading Co., Ltd. – Trademark Portfolio
Entity Type: 16
Xi'an Jiefang Trading Co., Ltd. has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as VISUABOT. Filings span 3 Nice Classification classes, with the highest activity in Class 9 (Computers & Electronics) and Class 7 (Machinery). This trademark owner is based in Xi'an, Shaanxi.
Room 101, Building 12, Zone 2, Curvature Engine Photon Manufacturing Park, No. 3000 Biyuan 3rd Road, High tech Zone,
Xi'an, Shaanxi 710000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xi'an Jiefang Trading Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Xi'an Jiefang Trading Co., Ltd. have?
Xi'an Jiefang Trading Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Xi'an Jiefang Trading Co., Ltd. file in?
Xi'an Jiefang Trading Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 7 (Machinery), Class 12 (Vehicles). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Xi'an Jiefang Trading Co., Ltd.'s most well-known trademarks?
Xi'an Jiefang Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as VISUABOT. These are among 2 currently registered trademarks in the portfolio.
What is Xi'an Jiefang Trading Co., Ltd.'s trademark registration success rate?
Xi'an Jiefang Trading Co., Ltd. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.